<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNA, miR) are negative regulators of gene expression that play an important role in diverse biological processes such as development, cell growth, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and haematopoiesis, suggesting their association with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we analysed the expression signatures of 157 miRNAs in 58 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), 46 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) and seven non-neoplastic lymph nodes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Comparison of the possible combinations of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>-, FL- and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> resulted in specific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>- and FL-signatures, which include miRNAs with previously published function in haematopoiesis (MIRN150 and MIRN155) or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> development (MIRN210, MIRN10A, MIRN17-5P and MIRN145) </plain></SENT>
<SENT sid="3" pm="."><plain>As compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>, some miRNAs are differentially regulated in both <z:hpo ids='HP_0002665'>lymphoma</z:hpo> types (MIRN155, MIRN210, MIRN106A, MIRN149 and MIRN139) </plain></SENT>
<SENT sid="4" pm="."><plain>Conversely, some miRNAs show <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-specific aberrant expression, such as MIRN9/9*, MIRN301, MIRN338 and MIRN213 in FL and MIRN150, MIRN17-5P, MIRN145, MIRN328 and others in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A classification tree was computed using four miRNAs (MIRN330, MIRN17-5P, MIRN106a and MIRN210) to correctly identify 98% of <z:hpo ids='HP_0000001'>all</z:hpo> 111 cases that were analysed in this study </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, eight miRNAs were found to correlate with event-free and overall survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> including known <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressors (MIRN21, MIRN127 and MIRN34a) and oncogenes (MIRN195 and MIRNLET7G) </plain></SENT>
</text></document>